Untitled Design (29)
Hazard & Dose-Response

Previous Teleseminars

Previous HDRSG Seminars – 2017-2023

Shraddha Karanth, University of Maryland
14 November, 2023

Integrating machine learning and quantitative structure activity relationship modeling approaches to build an artificial intelligence-assisted physiologically based pharmacokinetic model for nanoparticles in tumor-bearing mice
Wei-Chun Chou, University of Florida &

Leveraging machine learning and artificial intelligence to enhance toxicological sciences and physiologically based pharmacokinetic modeling
Zhoumeng Lin, University of Florida
12 September, 2023

Genetic Toxicology and Dose Response Data
George Johnson, Swansea University
13 June, 2023

Assessing effects of mixtures of Per and Polyfluoroalkyl Substances (PFAS) using transcriptomic points of departure
Gregory Addicks, Health Canada
7 March, 2023

Addressing Inter-individual Variabilities in Human Exposure and Toxicological Susceptibility in Environmental Risk and Impact Assessments
Dingsheng Li, University of Nevada, Reno
1 November, 2022

Accelerating QA review of PBPK models: A template approach to model implementation
Amanda Bernstein, U.S. EPA
13 September, 2022

Bayesian model averaging for BMD estimation: Extension of model sets and distributions
José Cortiñas Abrahantes, EFSA
7 June, 2022

Advancing the use of transcriptomic points of departure for regulatory decision-making
Carole Yauk, University of Ottawa
1 March, 2022

A new method for characterizing inter-species toxicodynamic variability
Sarah D. Burnett, Texas A&M University
2 November 2021

Individual, independent, and combined effects of toxic metals and manganese on hypertensive disorders of pregnancy
Michael Borghese, Health Canada

Chemical toxicity assessment using high-throughput transcriptomics and next generation sequencing: A case study of per- and polyfluoroalkyl substances
Anthony J.F. Reardon, Health Canada
2 March 2021

Concentration-response Analysis of Image-based High-throughput Phenotypic Profiling Data for Chemical Bioactivity Screening
Johanna Nyffeler, U.S. EPA
4 August 2020 | Video Presentation

High-throughput Transcriptomic Profiling of Chemicals for Risk Assessment Applications
Richard Judson, U.S. EPA
5 May 2020 | Video Presentation

Recent Probabilistic and Computational Advances in Dose-Response Assessment to Better Support Chemical Risk Assessment
Weihsueh Chiu, Texas A&M University
4 February 2020

Cox Proportional Hazard Regression and Splines: A Cautionary Tale for Exposure-Response Assessment
Dustin Long, University of Alabama Birmingham
5 March 2019

Differences Between Scientific, Legal, and Public Policy Uses of Probability
Nathan Schachtman, Esq., (SRA Risk Policy and Law Specialty Group)
7 August 2018

The NTP Proposed Approach to Genomic Dose-Response Modeling
Scott Auerbach, National Toxicology Program (NTP)
7 August 2018

New Data for Dose Response, Specifically Using Toxcast Data
Richard Judson, U.S. Environmental Protection Agency
3 April 2018

Machine Learning in Dose-Response Assessment: Translating Science to Decisions (Abstract)
Jacqueline MacDonald Gibson, University of North Carolina at Chapel Hill
6 March 2018

Considerations for the Dose‐Response Analyses of Inorganic Arsenic Health Outcomes
Jeff Gift, U.S. EPA
3 October 2017

Understanding the Biochemical Origin of Sigmoidal Dose Responses: Ultrasensitive Response Motifs
Qiang Zhang, Emory University
5 September 2017

Using 21st Century Science for Risk-related evaluations: An Overview of the NAS Risk21 Report
Jonathan Samet, George Daston, & Lauren Zeise, On behalf of the National Academies Risk21 Committee
1 August 2017

Exposure‐Response in Environmental Toxicology and Risk Assessment, from Receptors to Ecological Landscapes
Wayne G. Landis, Western Washington University
2 May 2017

Health and Economic Consequences of Endocrine Disruptors in the US and EU
Leo Transande, New York University
4 April 2017

Facilitated Discussion: Mentoring in Risk Assessment
2 February 2017